Research from Stanford University School of Medicine Provides New Study Findings on Antirheumatics (Phase II Trial of Regorafenib and Oral Methotrexate in Previously Treated Advanced KRAS-Mutant NSCLC)

Press/Media

PeriodNov 29 2024

Media coverage

1

Media coverage

  • TitleResearch from Stanford University School of Medicine Provides New Study Findings on Antirheumatics (Phase II Trial of Regorafenib and Oral Methotrexate in Previously Treated Advanced KRAS-Mutant NSCLC)
    Media name/outletClinical Trials Daily
    Country/TerritoryUnited States
    Date11/29/24
    PersonsSukhmani Kaur Padda
View all 1
View less

Related content